Craft

ATAI Life Sciences

Stock Price

$1.1

2024-10-29

Market Capitalization

$191.3 M

2024-10-29

Revenue

$308 K

FY, 2024

ATAI Life Sciences Summary

Company Summary

Overview
ATAI Life Sciences is a biotech company that operates a platform dedicated to mental health disorders curing. It leverages a technology platform for drug discovery, uses data approaches for existing molecules reposition, and provides digital therapeutics solutions. The company focuses on the development of solutions for people who suffer from depression, substance use disorder (SUD), and anxiety.
Type
Public
Status
Active
Founded
2018
HQ
Berlin, DE | view all locations
Website
https://www.atai.life/
Cybersecurity rating
Sectors

Key People

  • Christian Angermayer
  • Florian Brand
  • Rolando Gutierrez-Esteinou

    Rolando Gutierrez-Esteinou, Chief Medical Officer

  • Srinivas Rao

    Srinivas Rao, Co-Founder & Chief Scientific Officer

LocationsView all

1 location detected

  • Berlin, Berlin HQ

    Germany

    Krausenstraße 9-10

ATAI Life Sciences Financials

Summary Financials

Revenue (Q3, 2025)
$749.0K
Net income (Q3, 2025)
($61.1M)
Cash (Q3, 2025)
$30.4M
EBIT (Q3, 2025)
($28.4M)
Enterprise value
$163.8M

Footer menu